{"version":"1.0","provider_name":"Consulting Firm in Pharmaceutical, MedTech &amp; Healthcare","provider_url":"https:\/\/ceptonstrategies.com\/en","author_name":"Marc-Olivier B\u00e9vierre","author_url":"https:\/\/ceptonstrategies.com\/en\/author\/marc-olivier\/","title":"Gene therapy: the trap of biomanufacturing &#8211; Consulting Firm in Pharmaceutical, MedTech &amp; Healthcare","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"Fp6pYzEFWw\"><a href=\"https:\/\/ceptonstrategies.com\/en\/gene-therapy-trap-biomanufacturing\/\">Gene therapy: the trap of biomanufacturing<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/ceptonstrategies.com\/en\/gene-therapy-trap-biomanufacturing\/embed\/#?secret=Fp6pYzEFWw\" width=\"600\" height=\"338\" title=\"&#8220;Gene therapy: the trap of biomanufacturing&#8221; &#8212; Consulting Firm in Pharmaceutical, MedTech &amp; Healthcare\" data-secret=\"Fp6pYzEFWw\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2017\/12\/AAIA_wDGAAAAAQAAAAAAAAnIAAAAJDdlNmNiYzA2LWNkYzMtNDAwZC1hY2ZiLTczZTliMDAxMzgyNg.jpg","thumbnail_width":495,"thumbnail_height":266,"description":"Gene therapy: the trap of biomanufacturing With the recent approval of Yescarta and Kymriah CAR-T therapies in the US market, several years after approval of Glybera and Strimvelis in Europe, the therapeutic proof of concept of gene therapy has been validated. The next, though highly challenging, step for gene therapy development will be to bypass [&hellip;]"}